Top Markets
Coin of the day
Fresh2 Group Limited Fresh2 Group Limited

Fresh2 Group Limited

FRES
株式のランク #42683
Fresh2 Group Limited, a biotechnology company established in New York, New... Fresh2 Group Limited, a biotechnology company established in New York, New York, in 2010, officially adopted its current name in April 2023, having previously been known as AnPac Bio-Medical Science Co., Ltd. The company is primarily engaged in the research, development, promotion, and sale of advanced multi-cancer screening and detection tests within the People's Republic of China, leveraging its proprietary cancer differentiation analysis (CDA) technology and associated devices for corporate and life insurance clients. Beyond these core diagnostic offerings, Fresh2 Group provides comprehensive physical checkup packages and an array of technology services, including market research, design, software coding, development, and testing. The company also markets genetic testing kits and various skincare products. It owns several fundamental technology platforms and actively participates in further technological innovation and product distribution. Adding a unique dimension to its operations, Fresh2 Group also manages an e-commerce platform that facilitates connections between food suppliers and both supermarket operators and restaurant owners.
株価
$0.85
最終同期: 2025-01-21
時価総額
$411.40
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Fresh2 Group Limited (FRES)

カテゴリー

Fresh2 Group Limited(FRES)のP/E比率
August 2026 時点のP/E比率 TTM 0.00
Fresh2 Group Limited の最新の財務報告および株価によると、現在の P/E (TTM) は 0.00 です。2021 年末時点での P/E は 0.00 でした。
Fresh2 Group Limited の P/E 比率の履歴(2017 〜 2026)
各年末のP/E比率
P/E比率 変化
2026 (TTM) 0.00 -33.33%
2022 0.00 -33.33%
2021 0.00 -82.28%
2020 -0.03 -36.18%
2019 -0.04 -56.17%
2018 -0.09 -7.82%
2017 -0.10 0.00%
類似企業や競合他社のP/E比率
企業 P/E比率 P/E比率の差
28.05 -28,048,300.00%
US
31.14 -31,144,300.00%
NL
- -
CH
19.30 -19,298,800.00%
BE
- -
KR
P/E比率の読み方

株価収益率(P/E Ratio)は、企業の株価と1株あたり利益の関係を示します。
低いが正のP/Eは、現在の評価額に対して高い利益を上げている企業を示し、割安と見なされる可能性があります。高い負の(0に近い)P/Eは、損失が大きいことを示します。

P/Eが30を超えるか、負である企業は一般に「成長株」と見なされ、投資家は将来的な成長または黒字化を期待しています。

10未満の正のP/Eを持つ企業は一般に「割安株」と見なされ、既に収益性が高いが成長の余地は小さいと見なされます。